ESADoggy Announces its Annual Scholarship Program

The scholarship is open to high school seniors. ESADoggy will award $5,000 in scholarship to five winners.

Boca Raton, Florida – ESAD Int’l (ESADoggy) announces its annual ESADoggy Scholarship Program for 2022/23. The new scholarship program is aimed at students who exemplify compassion and excellence by providing financial support to health care students, computer science students, and active/retired service members.

The scholarship is open to high ..

American Green, Inc.™ (OTC:ERBB) CBD Water with Vessl Cap Technology launched on eBay Groupon and AmericanGreenCBD.com

The Vessl® Patented Delivery System Provides Rapid and Greater CBD Absorption for better and faster pain relief.

PHOENIX, AZ – American Green, Inc. (ERBB:OTC) announced today that it has launched Axis brand bottled Hemp water made with CBD isolate, on eBay.com, Groupon.com, and in its online store at AmericanGreenCBD.com. The Hemp is infused into the water by Vessl® Corporation’s patented Nitrogen-Pressurized Cap With Sonic, Nano- Emulsification which provide..

Missfresh Achieves Impressive Sales Growth of Ready Meals and Expands its Higher Margin ‘3R’ Product Categories

BEIJING, Jan. 24, 2022 /PRNewswire/ — Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF), a pioneer in China’s neighborhood retail industry, today announced its outstanding sales growth performance for Ready-to-Cook, Ready-to-Heat, and Ready-to-Eat products (referred to as 3R…

Společnost The Green Coffee Company získala v kole B 13,2 milionu dolarů, čímž se celkový investovaný kapitál zvýšil na 25 milionů dolarů a je na cestě k pozici největšího producenta kávy v Kolumbii

MEDELLÍN, Kolumbie, 24. ledna 2022 /PRNewswire/ – Společnost The Green Coffee Company (GCC), která je součástí Legacy Group, s potěšením oznamuje, že v kole série B dosáhla kapitálového cíle, který nedávno kvůli vysoké poptávce navýšila o 3,5 milionu dolarů na 13,2 milionu dolarů. V…

JinkoSolar’s Subsidiary Jinko Solar Co., Ltd. to be Listed on Shanghai Stock Exchange on January 26, 2022

SHANGRAO, China, Jan. 24, 2022 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its principal operating subsidiary, Jinko Solar Co., Ltd., will be…

Suzhou Municipal Bureau of Culture, Radio, Television and Tourism Named Headline Sponsor of London’s International Media Marketplace

NEW YORK, Jan. 24, 2022 /PRNewswire/ — The Suzhou Municipal Bureau of Culture, Radio, Television and Tourism is pleased to announce its headline sponsorship of IMM London which will take place 14-15 March 2022. Now in its tenth year, IMM is firmly established as the leading global event…

$JBC Tokens – An Admit Ticket to avail Multifarious Utilities, Splendid Perks, and Excellent Crypto Services

BRISBANE CITY, Australia, Jan. 24, 2022 /PRNewswire/ — Jungle Book Crypto, a committed cryptocurrency hub, is triumphantly back with its series of modern-day crypto-based products and brand-new presale of $JBC tokens. The platform has broadened the frontiers of the crypto jungle with the…

NanoMosaic Signs 31K Square Foot Lease and Establishes “Multi-Omics World Headquarters” in Waltham, MA

BOSTON, Jan. 24, 2022 /PRNewswire/ — NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications has announced that it has signed a lease for a standalone building of 30,880 square feet…

CEOs Eye 2022 With Optimism and a Dash of Uncertainty

NEW YORK, Jan. 24, 2022 /PRNewswire/ — Key takeaways: Nearly two-thirds of CEOs expect their organization’s growth to be “very strong” or “strong” over the next 12 months. Concerns about financial market instability and inflation have risen sharply with 36% of CEOs naming it as among the…

Viking Therapeutics Announces Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD

SAN DIEGO, Jan. 24, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its Phase 1b clinical trial of VK0214 in…

« Previous Page — Next Page »